These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 16683337

  • 1. [Public health and chemical-pharmaceutical companies].
    Ribeiro MA.
    Hist Cienc Saude Manguinhos; ; 7(3):607-26. PubMed ID: 16683337
    [Abstract] [Full Text] [Related]

  • 2. [Laqueur and organon: the university laboratory and the pharmaceutical industry in the Netherlands].
    Oudshoorn N.
    Tijdschr Geschied Geneeskd Natuurwet Wiskd Tech; 1999; 22(1):12-22. PubMed ID: 20677414
    [No Abstract] [Full Text] [Related]

  • 3. Brazil: An emerging partner in drug R&D.
    Rodrigues DG.
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [Abstract] [Full Text] [Related]

  • 4. The Brazilian vaccine manufacturers' perspective and its current status.
    Homma A.
    Biologicals; 2009 Jun; 37(3):173-6. PubMed ID: 19423359
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Panel discussion on vaccine development to meet U.S. and international needs. When manufacturers are unwilling to accept the risks or invest the capital: vaccine production by the Salk Institute to specifications of the U.S. Army.
    French GR.
    AIDS Res Hum Retroviruses; 1994 Jun; 10 Suppl 2():S309. PubMed ID: 7865328
    [No Abstract] [Full Text] [Related]

  • 12. Vaccines, public health and social care.
    Chast F.
    Ann Pharm Fr; 2012 Nov; 70(6):307-8. PubMed ID: 23177556
    [No Abstract] [Full Text] [Related]

  • 13. [Remedy or painkiller? Concentration trends in Dutch pharmaceutical industry].
    De Jong HW.
    Gewina; 1999 Nov; 22(1):46-57. PubMed ID: 11625501
    [Abstract] [Full Text] [Related]

  • 14. [Development of the chemico-pharmaceutical industry in the Ukrainian RSR].
    Ena MG.
    Farm Zh; 1965 Nov; 20(5):69-74. PubMed ID: 4866786
    [No Abstract] [Full Text] [Related]

  • 15. The future of best investing in vaccines: the Health Technology Assessment approach.
    La Torre G, de Waure C, Chiaradia G, Mannocci A, Specchia ML, Nicolotti N, Ricciardi W.
    Vaccine; 2008 Mar 20; 26(13):1609-10. PubMed ID: 18289744
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Future challenges and prospects for drug companies].
    Lajoux C.
    Bull Acad Natl Med; 2008 Apr 20; 192(4):623-30; discussion 630-2. PubMed ID: 19024935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.